Aptamer-antibody hybrid ELONA that uses hybridization chain reaction to detect a urinary biomarker EN2 for bladder and prostate cancer.

Autor: Kim, Eunseon1 (AUTHOR), Kang, Minji1 (AUTHOR), Ban, Changill1 (AUTHOR) ciban@postech.ac.kr
Zdroj: Scientific Reports. 7/7/2022, Vol. 12 Issue 1, p1-8. 8p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje